Precision BioSciences Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | -26.1% | +90.7% | +69.7% | -36.2% | +40.9% | +12.6% | -32.9% | -14.6% | +13.2% | |
| – | -31.9% | +79.8% | +67.4% | -45.5% | +53.2% | +23.1% | -31.5% | -30.3% | +25.0% | |
| – | -32.8% | +64.3% | +75.3% | -50.4% | +60.0% | +32.0% | -38.5% | -26.4% | +29.0% | |
| – | -32.8% | +64.3% | +75.3% | -50.4% | +60.0% | +32.0% | -38.5% | -26.0% | +33.9% | |
| – | -94.3% | +2,277.3% | +84.5% | +936.3% | -95.1% | +47.5% | +1,677.5% | -86.7% | -100.0% | |
| – | – | – | – | -39.3% | +202.6% | -56.7% | – | – | – | |
| – | +129.6% | +159.9% | +87.1% | +4.9% | -39.4% | -19.7% | – | – | – | |
| – | -68.0% | +1,528.9% | -2.3% | -4.1% | +49.2% | -64.3% | -45.3% | +55.5% | +87.5% | |
| – | -4.0% | -0.4% | -1.7% | +9.1% | +13.8% | +47.7% | -20.7% | -43.2% | -22.3% | |
| – | +10.3% | +52.9% | +91.3% | +59.0% | -16.0% | +65.8% | -16.2% | -70.0% | -40.5% | |
| – | – | +115.9% | +109.9% | -71.7% | -5.7% | -7.9% | +1,303.2% | -94.4% | +14.2% | |
| – | +40.4% | +22.8% | -8.2% | -61.1% | +44.4% | -42.9% | +354.5% | -55.8% | -77.4% | |
| – | – | – | – | – | – | +796.8% | – | – | +0.4% | |
| – | – | – | +246.1% | -67.9% | +105.2% | -33.7% | -68.8% | +199.0% | +63.6% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | -93.3% | +45.7% | -14.3% | +23.9% | +12.8% | +49.8% | +31.1% | +79.2% | +86.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.